Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: Antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma

Laryngoscope

Volumn 122, Issue 8, 2012, Pages 1724-1733

  Bussu, Francesco ^a   Ranelletti, Franco O ^a   Gessi, Marco ^a   Graziani, Cristina ^a   Lanza, Paola ^b   Lauriola, Libero ^a   Paludetti, Gaetano ^a   Almadori, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Laryngeal squamous cell carcinoma; prognosis; quantitative immunohistochemistry; radioligand binding assay; type I receptor tyrosine kinases

Indexed keywords

CYCLINE; CYTOKERATIN 14; CYTOKERATIN 17; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR LOCALIZATION SIGNAL; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; KERATIN-14; KERATIN-17; LARYNGEAL MUCOSA; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNX; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 84864405429     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23311     Document Type: Article

References (49)

1. Yarden Y, Sliwkowski MX,. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2: 127-137. (Pubitemid 33674041)
2. Olayioye MA, Neve RM, Lane HA, Hynes NE,. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000; 19: 3159-3167. (Pubitemid 30428195)
3. Schlessinger J,. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004; 306: 1506-1507. (Pubitemid 39564935)
4. Burden S, Yarden Y,. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 1997; 18: 847-855. (Pubitemid 27274603)
5. Tzahar E, Pinkas-Kramarski R, Moyer JD, et al. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J 1997; 16: 4938-4950. (Pubitemid 27348403)
6. Xia W, Lau YK, Zhang HZ, et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999; 5: 4164-4174. (Pubitemid 30013801)
7. Bei R, Budillon A, Masuelli L, et al. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. J Pathol 2004; 204: 317-325. (Pubitemid 39430092)
8. Riesterer O, Milas L, Ang KK,. Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. J Clin Oncol 2007; 25: 4075-4083. (Pubitemid 47495867)
9. Rafferty MA, Fenton JE, Jones AS,. An overview of the role and inter-relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. Clin Otolaryngol Allied Sci 2001; 26: 317-320. (Pubitemid 32955513)
10. Rubin GJ, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998; 90: 824-832. (Pubitemid 28280548)
11. Gale N, Kambic V, Poljak M, et al. Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions. Oncology 2000; 58: 117-125. (Pubitemid 30113862)
12. Watanabe H, Suzuki T, Ito Y, et al. Prognostic significance of EGFR and p53 expression, and angiogenesis in laryngeal squamous cell carcinoma [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 1999; 102: 243-253.
13. Almadori G, Cadoni G, Galli J, et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer 1999; 84: 188-191. (Pubitemid 29133831)
14. Maurizi M, Almadori G, Ferrandina G, et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996; 74: 1253-1257. (Pubitemid 26360115)
15. Weinstein GS, Nuamah IF, Tucker J, Montone K,. Evaluation of HER-2/neu (c-erbB-2) oncogene expression in whole organ sections of supraglottic squamous cell carcinoma. Ann Otol Rhinol Laryngol 1996; 105: 275-279. (Pubitemid 26121579)
16. Tantawy A, Youins L, Hamza M,. Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation to invasion of the cartilagenous framework and prognosis. Eur Arch Otorhinolaryngol 1999; 256: 72-77. (Pubitemid 29132467)
17. Cavalot A, Martone T, Roggero N, et al. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas. Head Neck 2007; 29: 655-664. (Pubitemid 47168236)
18. Krecicki T, Jelen M, Zalesska-Krecicka M,. C-erbB-2 immunostaining in laryngeal cancer. Acta Otolaryngol 1999; 119: 392-395. (Pubitemid 29227408)
19. Kazkayasi M, Hucumenoglu S, Siriner GI, Hucumenoglu M,. Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2001; 258: 329-335. (Pubitemid 32930190)
20. Thybusch-Bernhardt A, Beckmann S, Juhl H,. Comparative analysis of the EGF-receptor family in pancreatic cancer: expression of HER-4 correlates with a favourable tumor stage. Int J Surg Investig 2001; 2: 393-400.
21. Suo Z, Risberg B, Kalsson MG, et al. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol 2002; 196: 17-25.
22. Rotterud R, Nesland JM, Berner A, Fossa SD,. Expression of the epidermal growth factor receptor family in normal and malignant urothelium. BJU Int 2005; 95: 1344-1350. (Pubitemid 40799457)
23. Almadori G, Bussu F, Gessi M, et al. Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma. Eur J Cancer 2010; 46: 1144-1152.
24. Bosch FX, Ritter D, Enders C, et al. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value. Int J Cancer 2004; 111: 530-538. (Pubitemid 39045319)
25. Bussu F, Almadori G, De CE, et al. Endoscopic horizontal partial laryngectomy by CO(2) laser in the management of supraglottic squamous cell carcinoma. Head Neck 2009; 31: 1196-1206.
26. Ranelletti FO, Almadori G, Rocca B, et al. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 2001; 95: 343-349. (Pubitemid 33015102)
27. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
28. Shah JP, Karnell LH, Hoffman HT, et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 1997; 123: 475-483. (Pubitemid 27212842)
29. Licitra L, Bernier J, Grandi C, et al. Cancer of the larynx. Crit Rev Oncol Hematol 2003; 47: 65-80. (Pubitemid 36802324)
30. Almadori G, Bussu F, Cadoni G, et al. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 2005; 41: 683-693. (Pubitemid 40342550)
31. Liu M, Lawson G, Delos M, et al. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol 2003; 260: 28-34. (Pubitemid 36207658)
32. Bei R, Pompa G, Vitolo D, et al. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 2001; 195: 343-348.
33. Stoll SW, Kansra S, Peshick S, et al. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia 2001; 3: 339-350. (Pubitemid 32801884)
34. Maguire HC Jr, Jaworsky C, Cohen JA, et al. Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol 1989; 92: 786-790. (Pubitemid 19166602)
35. Chow NH, Chan SH, Tzai TS, Ho CL, Liu HS,. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin Cancer Res 2001; 7: 1957-1962.
36. Weidner U, Peter S, Strohmeyer T, et al. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res 1990; 50: 4504-4509. (Pubitemid 20230383)
37. Prigent SA, Lemoine NR, Hughes CM, et al. Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 1992; 7: 1273-1278.
38. Srinivasan R, Poulsom R, Hurst HC, Gullick WJ,. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol 1998; 185: 236-245. (Pubitemid 28320044)
39. Srinivasan R, Gillett CE, Barnes DM, Gullick WJ,. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res 2000; 60: 1483-1487. (Pubitemid 30183410)
40. Barnes NL, Khavari S, Boland GP, et al. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 2005; 11: 2163-2168. (Pubitemid 40490173)
41. Memon AA, Sorensen BS, Melgard P, et al. Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br J Cancer 2004; 91: 2034-2041. (Pubitemid 40128770)
42. Andersson U, Guo D, Malmer B, et al. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol 2004; 108: 135-142. (Pubitemid 39136299)
43. Earp HS III, Calvo BF, Sartor CI,. The EGF receptor family-multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4. Trans Am Clin Climatol Assoc 2003; 114: 315-333.
44. Lo HW, li-Seyed M, Wu Y, et al. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 2006; 98: 1570-1583. (Pubitemid 44141861)
45. Giri DK, li-Seyed M, Li LY, et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 2005; 25: 11005-11018. (Pubitemid 41747142)
46. Zhou W, Carpenter G,. Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem 2000; 275: 34737-34743.
47. Ni CY, Murphy MP, Golde TE, Carpenter G,. gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294: 2179-2181. (Pubitemid 33150677)
48. Erjala K, Sundvall M, Junttila TT, et al. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Clin Cancer Res 2006; 12: 4103-4111. (Pubitemid 44078099)
49. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578. (Pubitemid 43209104)